Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 3 1

Status

Completed 5Terminated 4Recruiting 4Withdrawn 2Not yet recruiting 2Active not recruiting 2

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Genitourinary 5Endocrine 1

Conditions

Carcinoma, Renal Cell 5Urologic Neoplasms 1Urinary Bladder Neoplasms 1Pulmonary Embolism 1Adrenal Gland Neoplasms 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Nephrectomy × Clear all
NCT00930033 2025-09-05

CARMENA

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed
452 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT03473730 2025-01-30

Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Completed
17 enrolled
Genitourinary

Carcinoma, Renal Cell, Urologic Neoplasms

NCT04402749 2023-03-16

The Incidence of Pulmonary Embolism During Nephrectomy

Mahidol University

Completed
416 enrolled
Genitourinary

Carcinoma, Renal Cell, Pulmonary Embolism

NCT04570176 2022-02-16

Efficacy and Safety of Clinical Telesurgery Using Chinese Independently Developed Surgical Robot System

The Affiliated Hospital of Qingdao University

Phase NA Completed
1 enrolled
EndocrineGenitourinary

Adrenal Gland Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Renal Cell

NCT04309617 2021-05-19

Retrospective Study on Referral Patterns for High Risk Patients Post Nephrectomy

Pfizer

Completed
618 enrolled 33 charts
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡